Clostridium difficile: an update

Compr Ther. 2004 Fall-Winter;30(3):134-40. doi: 10.1007/s12019-004-0009-z.

Abstract

Clostridium difficile causes a spectrum of diarrheal illness with the potential for major medical consequences. Although most cases respond quickly to treatment, C. difficile colitis may be severe and life threatening. Recurrent disease represents a particularly challenging problem.

Publication types

  • Review

MeSH terms

  • Anion Exchange Resins / therapeutic use
  • Anti-Infective Agents / therapeutic use
  • Clostridioides difficile
  • Enterocolitis, Pseudomembranous / diagnosis*
  • Enterocolitis, Pseudomembranous / epidemiology
  • Enterocolitis, Pseudomembranous / physiopathology
  • Enterocolitis, Pseudomembranous / therapy*
  • Humans
  • Immunotherapy
  • Metronidazole / therapeutic use
  • Rifampin / therapeutic use
  • Secondary Prevention
  • United States / epidemiology
  • Vancomycin / therapeutic use

Substances

  • Anion Exchange Resins
  • Anti-Infective Agents
  • Metronidazole
  • Vancomycin
  • Rifampin